Clinical trials
Terminated Phase 3 Lymphoma, T-Cell, Cutaneous trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2017 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Elorac, Inc. | 1 |
| Emergent Product Development Seattle LLC | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| OHSU Knight Cancer Institute | 1 |
| Soligenix | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Cutaneous | 5 |
| Mycosis Fungoides | 5 |
| Sezary Syndrome | 4 |
| Lymphoma | 2 |
| Blast Crisis | 1 |
| Breast Neoplasms | 1 |
| Burkitt Lymphoma | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Congenital Abnormalities | 1 |
| Gestational Trophoblastic Disease | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.